ArticleNeurosurgery practice2025
The Neurosurgical Management of Pancoast Tumors: Neurological Function and Survival Outcomes With a Brachial Plexus Preserving Operative Technique.
Article in Neurosurgery practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesSurgical management of Pancoast tumors requires collaboration between thoracic surgeons and neurosurgeons. Minimal literature exists on the management of these patients from a neurosurgical perspective regarding operative technique and its impact on short-term neurological function and long-term survival.
methodsPatients at a National Cancer Institute-designated cancer center were prospectively enrolled in an Institutional Review Board-approved study. Those patients surgically treated for Pancoast tumors were identified. Patient demographics, tumor characteristics, preoperative and postoperative measurements, and discharge disposition were collected. Outcome measures included neurological function and overall survival. Basic descriptive statistics were performed to summarize cumulative data for each measurement recorded.
resultsNineteen patients were included in the study. The mean age was 59 + 7.88 years, and 42.11% (n = 8) were female. 43.75% (n = 7) were staged as T3 and 56.25% (n = 9) as T4. 89.47% (n = 17) had preoperative chemoradiotherapy (Table 1). 89.47% (n = 17) and 21.05% (n = 4) presented with upper extremity pain and paresthesia, respectively. 57.89% (n = 11) presented with respiratory symptoms. The mean time from diagnosis to surgery was 143.53 + 39.87 days (Table 2). 100% underwent resection of apical tumor and chest wall, with complete removal achieved in 89.47% (n = 17). Complications occurred in of 21.05% (n = 4) patients, no major complications. Average follow-up was 3.83 + 3.11 years. 10.53% (n = 2) had decrease in motor function from baseline (
conclusionOur case series highlights the importance of neurosurgical involvement and expected outcomes in managing Pancoast tumors. Given the neurosurgeon's critical role in tumor resection, further studies highlighting neurosurgical management of Pancoast tumors are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.